Abstract
Percutaneous coronary interventions and stenting have existed since the 1970s. Stents can be made of different materials and have different designs. A complication to the intervention and especially to bare metal stents is in-stent restenosis with neointimal proliferation and chronic inflammation, which has several causes briefly discussed below. A possible association between stents and metal allergy has been investigated. With regard to stents, studies have been mainly retrospective, in itself a limitation, and show somewhat disparate results. This chapter will focus on some of these findings but also on general knowledge of stents and what happens in the vessel. This insight is meant to assist those who advise patients and cardiologists and who investigate patients with stents where question of metal allergy is raised.
References
Grüntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet. 1978;1:263.
Sugwart U, Puel J, Mirkovitch V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987;316:701–6.
Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent-implantation with balloon angioplasty in patients with coronary artery disease. Benestent study group. N Engl J Med. 1994;331:489–95.
Bauters C, Meurice T, Hamon M, et al. Mechanisms and prevention of restenosis: from experimental models to clinical practice. Cardiovascular Re. 1996;31:835–56.
Serruys PW, Unger F, Sousa JE, et al. Comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease. N Enl J Med. 2001;344:1117–24.
Lindholm D, Curr JS. Bioresorbable stents in PCI. Current cardiology reports. Curr Cardiol Rep. 2016;18:74.
Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet. 2007;370:937–48.
Simard T, Hibbert B, Ramirez FD, et al. The evolution of coronary stents: a brief review. Can J Cardiol. 2014;30:35–45.
Sarno G, Lagerqvist B, Nilsson J, et al. Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR. J Am Coll Cardiol. 2014;64:16–24.
Taniwaki M, Rau MD, Zaugg D, et al. Mechanisms of very late drug-eluting stent thrombosis assessed by optical coherence tomography. Circulation. 2016;133:650–60.
Cook S, Wenaweser P, Togni M, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007;115:2426–34.
Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;4881:193–202.
Otsuka F, Vorphal M, Nakano M, et al. Pathology of second-generation everolimus-eluting stents versus first generation sirolimus-and paclitaxel-eluting stents in humans. Circulation. 2014;129:211–23.
Joner M, Koppara T, Virmani R, et al. Improving vessel healing with fully bioresorbable drug-eluting stents: more than a pipe dream. Eur Heart J. 2016;37:241–4.
Iqbal J, Onuma Y, Ormiston J, et al. Bioresorbable scaffolds: rationale, current status, challenges, and future. Eur Heart J. 2014;35:765–76.
Fuster V, Mearns B. The CVD paradox: mortality vs prevalence. Nat Rev Cardiol. 2009;96:669.
Jorge C, Dubois C. Clinical utility of platinum chromium bare-metal stents in coronary heart disease. Med Devices (Auckl). 2015;8:359–67.
Iannaccone M, D'Ascenzo F, Templin C, et al. Optical coherence tomography evaluation of intermediate-term healing of different stent types: systemic review and meta-analysis. Eur Heart J Cardiovasc Imaging. 2016;pii:jew070. [Epub ahead of print]
Whittaker DR, Fillinger MF. The engineering of endovascular stent technology: a review. Vasc Endovasc Surg. 2006;40:85–94.
Honorari G, Ellis SG, Wilkoff BL, et al. Hypersensitivity reactions associated with endovascular devices. Contact Dermatitis. 2008;59:7–22.
Gotman I. Characteristics of metals used in implants. J Endourl. 1997;11:383–9.
Mennuni MG, Pagnotta PA, Stefanini GG. Coronary stents: the impact of technological advances on clinical outcomes. Ann Biomed Eng. 2016;44:488–96.
Stefanini GG, Holmes DR. Drug eluting coronary-artery stents. N Engl J Med. 2013;368:254–65.
Zhang Y, Bourantas CV, Farooq V, et al. Bioresorbable scaffolds in the treatment of coronary artery disease. BMC Cardiovas Disord. 2016;16:38. doi:10.1186/s12872-016-0207-5.
Ma X, Wu T, Robich MP. Drug eluting stents. Int J Clin Exp Med. 2012;3:192–201.
Schild HH, Strunk H. Biological effects of metallic stents. Chapter 9. In: Schild HH, Strunk H, editors. Textbook of metallic stents, Adam A, Dondelinger R, Mueller P, series editors. Oxford: ISIS, Medical Media; 1997. p. 175–186.
Rousseau H, Puel J, Joffre F, et al. Self expanding endovascular prosthesis: an experimental study. Radiology. 1987;164:709–14.
Chaabane C, Otsuka F, Virmani R, et al. Biological responses in stented arteries. Cardiovasc Res. 2013;99:353–63.
Consigny PM, Tulenko TN, Nicosia RF. Immediate and long-term effects of angioplasty on normal rabbit iliac artery. Arteriosclerosis. 1986;6:265–76.
Lindner V, Lappi D, Baird A, et al. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res. 1991;68:106–13.
Palmaz FC, Tio FO, Schatz RA, et al. Early endothelialization of balloon expandable stents: experimental observations. J Intervent Radiol. 1998;3:119–24.
Palmaz FC, Windeler SA, Garcia F, et al. Artheriosclerotic rabbit aortas: expandable intraluminal grafting. Radiology. 1986;160:723–6.
Van der Heiden K, Gijsen FJ, Narracott A, et al. The effects of stenting on shear stress: relevance to endothelial injury and repair. Cardiovasc Res. 2013;99:269–75.
Maass D, Demiere D, Deaton D, et al. Transluminal implantation of self-adjustable expanding prosthesis: principles, techniques and results. Prog Artif Organs. 1983;2:979.
Beyar R, Shofti R, Grenedier F, et al. Coronary arterial histological response to the self expandable nitinol stent. J Am Coll Cardiol. 1993;21:336A.
Beyar R, Shofti R, Grenedier F, et al. Self expandable nitinol stent for cardiovascular applications: canine and human experience. Catheter Cardiovasc Diagn. 1994;3:162–70.
Schwartz SM, Campbell GR, Campbell JH. Replication of smooth muscle cells in vascular disease. Circ Res. 1986;58:427.
Farb A, Kolodgie FD, Hwang JY, et al. Extracellular matrix changes in stented human coronary arteries. Circulation. 2004;110:940–7.
Curcio A, Torella D, Indolfi C. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy. Circ J. 2011;75:1287–96.
Sousa JE, Costa MA, Abizaid AC, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation. 2001;104:2007–11.
Stone GW, Ellis SG, Cox DA, TAXUS-IV Investigators, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221–31.
Granada JF, Inami S, Aboodi MS, et al. Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix. Circ Cardiovasc Interv. 2010;3:257–66.
Douglas G, Van Kampen E, Hale AB, et al. Endothelial cell repopulation after stenting determines in-stent neointima formation: effects of bare metal vs drug-eluting stents and genetic endothelial cell modification. Eur Heart J. 2013;34:3378–88.
World Health Organization. International programme on chemical safety, immunotoxicity, Harmonization Project Document No 10. Guidance for immunotoxicity Risk Assessments for Chemicals. This project was conducted within the WHO/International Programme on Chemical Safety Project on the Harmonization of Approaches to the Assessment of Risk from Exposure to Chemicals, WHO Library Cataloguing-in-Publication Data ISBN 978 92 4 150330 3 Printed by the WHO Document Production Services, Geneva, Switzerland 2011 (available from: http://www.who.int/ipcs/methods/harmonization/areas/immunotoxicity/en/) accessed 27 Jul 2016.
Fischer A, Wieneke H, Brauer H, et al. Metallic biomaterials for coronary stents. Z Kardiol. 2001;90:251–62.
Scmidt M, Raghavan B, Muller V, et al. Crucial role for human toll-like receptor 4 in the development of contact allergy to nickel. Nat Immunol. 2010;11:814–9.
Raghavan B, Martin SF, Esser PR, et al. Metal allergens nickel and cobalt facilitate TLR4 homodimerization independently of MD2. EMBO Rep. 2012;13:1109–15.
Svedman C, Möller H, Gruvberger B, et al. Implants and contact allergy: are sensitizing metals released as haptens from coronary stents? Contact Dermatitis. 2014;2014:92–7.
Schmalz GP, Garhammer P, Reitinger T. Metal content of biopsies from neighborhood of casting alloys. J Dent Res. 1999;7:236. Abstract No. 1048
Dimic ID, Cvijovic-Alagic IL, Kostic IT, et al. Metallic ion release from biocompatible cobalt-based alloy. Chem Ind Chem Eng Q. 2014;20:571–7.
Rachmawati D. Innate immune reactivity to dental alloys. Thesis, Vrije Universiteit, Amsterdam, 2016.
Gong Z, Li M, Guo X, et al. Stent implantation in patients with metal allergy: a systemic review and meta-analysis. Coron Artery Dis. 2013;24:684–9.
Koster R, Vieluf D, Kiehn M, et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet. 2000;356:1895–7.
Hillen U, Haude M, Erbel R, et al. Evaluation of metal allergies in patients with coronary stents. Contact Dermatitis. 2002;47:353–6.
Iijima R, Iakri Y, Amiya E, Tanimoto S, Nakazawa G, et al. The impact of metallic allergy on stent implantation: metal allergy and recurrence of in-stent restenosis. Int J Cardiol. 2005;104:319–25.
Norgaz T, Hobioglu G, Serdar ZA, et al. Is there a link between nickel allergy and coronary stent restenosis? Tohoku J Exp Med. 2005;206:243–6.
Saito T, Hokimoto S, Oshima S, et al. Metal allergic reaction in chronic refractory in-stent restenosis. Cardiovasc Revasc Med. 2009;10:17–22.
Svedman C, Ekqvist S, Möller H, et al. A correlation found between contact allergy to stent material and restenosis of the coronary arteries. Contact Dermatitis. 2009;60:158–64.
El-Mawardy R, Fuad H, Abdel-Salam Z, et al. Does nickel allergy play a role in the development of in-stent restenosis? Eur Rev Med Pharmacol Sci. 2011;15:1235–40.
Thyssen JP, Engkilde K, Menné T, et al. No association between metal allergy and cardiac in-stent restenosis in patients with dermatitis-results from a linkage study. Contact Dermatitis. 2011;64:138–41.
Aliağaoğlu C, Turan H, Erden I, et al. Relation of nickel allergy with in-stent restenosis in patients treated with cobalt chromium stents. Ann Dermatol. 2012;24:426–9.
Ekqvist S, Svedman C, Möller H, et al. High frequency of contact allergy to gold in patients with endovascular coronary stents. Br Journal of Dermatology. 2007;157:730–8.
Ekqvist S, Svedman C, Lundh T, et al. A correlation found between gold concentration in blood and patch test reactions in patients with coronary stents. Contact Dermatitis. 2008;59:137–42.
Nakazawa G, Tanabe K, Aoki J. Sirolimus-eluting stents suppress neointimal formation irrespective of metallic allergy. Circ J. 2008;72:893–6.
Shokri M, Bagheri B, Garjani A. Everolimus-eluting stents reduce monocyte expression of toll-like receptor 4. Adv Pharm Bull. 2015;5:643–7.
Hansen PR, Ahlehoff O, Gislason GH, et al. Absence of metal allergy in patients with very late drug-eluting stent thrombosis: a pilot study. Int J Cardiol. 2010;145:629–30.
Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667–78.
Wenaweser P, Daemen J, Zwahlen M, et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol. 2008;52:1134–40.
Chatterjee S, Pandey A. Drug eluting stents: friend or foe? A review of cellular mechanisms behind the effects of paclitaxel and sirolimus eluting stents. Curr Drug Metab. 2008;9:554–66.
Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004;109:701–5.
Nebeker JR, Virmani R, Bennett CL, et al. Hypersensitivity cases associated with drug eluting coronary stents. JACC. 2006;47:175–81.
Van der Giessen WJ, Lincoff AM, Schwartz RS, et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation. 1996;94:1690–7.
Tenekecioglu E, Farooq V, Bourantas CV, et al. Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention. BMC Cardiovasc Disord. 2016;16:38. Published online
Otsuka F, Yahagi K, Ladich E, et al. Hypersensitivity reaction in the US Food and Drug Administration-approved second-generation drug-eluting stents: histopathological assessment with ex vivo optical coherence tomography. Circulation. 2015;13:322–4.
Nikam N, Steinberg D, Steinberg T. Advances in stent technologies and their effect on clinical efficacy and safety. J Allergy Clin Immunol Pract. 2015;3:683–95.
Thyssen JP, Menné T, Schalock PC, et al. Pragmatic approach to the clinical work-up of patients with putative allergic disease to metallic orthopedic implants before and after surgery. Br J Dermatol. 2011;164:473–8.
Schalock PC, Menné T, Johansen JD. Hypersensitivity reactions to metallic implants-diagnostic algorithm and suggested patch test series for clinical use. Contact Dermatitis. 2011;66:4–19.
Liden C, Bruze M. Kontaktallergi mot ortopediska metallimplantat är svårbedömd. Lakartidningen. 2016;113:D6L9.
Kieffer M. Nickel sensitivity: relationship between history and patch test reaction. Contact Dermatitis. 1979;5:398–401.
Svedman C, Dunér K, Kehler M, et al. Lichenoid reactions to gold from dental restorations and exposure to gold through intracoronary implant of a gold-plated stent. Clin Res Cardiol. 2006;95:689–91.
Ahnlide I, Ahlgren C, Björkner B, et al. Gold concentration in blood in relation to the number of gold restorations and contact allergy to gold. Acta Odontol Scand. 2002;60:301–5.
Ekqvist S, Lundh T, Svedman C, et al. Does gold concentration in blood influence the result of patch testing to gold? Br J Dermatol. 2009;160:1016–21.
Lai DW, Saver JL, Araujo JA, et al. Pericarditis associated with nickel hypersensitivity to Amplatzer occluder device: a case report. Catheter Cardiovasc Interv. 2005;66:424–6.
Fall S, Bruze M, Isaksson M, et al. Contact allergy trends in Sweden - a retrospective comparison of patch test data from 199, 2000, and 2009. Contact Dermatitis. 2015;201572:297–304.
Thyssen JP, Linneberg A, Menné T, et al. Contact allergy to allergens of the TRUE-test (panels 1 and 2) has decreased modestly in the general population. Br J Dermatol. 2009;161:1124–9.
Acknowledgements
We would like to thank CG Gustavsson, cardiologist and associate professor, University of Lund, Malmö, for revising and providing fruitful comments to the text.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Svedman, C., Bruze, M. (2018). Hypersensitivity to Cardiovascular Implants: Stents. In: Chen, J., Thyssen, J. (eds) Metal Allergy. Springer, Cham. https://doi.org/10.1007/978-3-319-58503-1_20
Download citation
DOI: https://doi.org/10.1007/978-3-319-58503-1_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-58502-4
Online ISBN: 978-3-319-58503-1
eBook Packages: MedicineMedicine (R0)